LETTERS TO THE EDITOR
Is meconium ileus genetically determined or associated with a more severe evolution of cystic fibrosis?
Cystic fibrosis (CF) is the most common, lethal, autosomal recessive childhood disorder in the white population, occurring in about 1 in 2500 live births.' The incidence is 1 in 936 live births, with a carrier rate of 1 in 15 inhabitants of Saguenay Lac-SaintJean, a geographically isolated region in north eastern Quebec2' (unpublished results).
One hundred and sixty-six patients from 143 families are known at the Clinique de la Fibrose Kystique of the Complexe Hospitalier de la Sagamie in Chicoutimi (Saguenay), which is the referral centre for the whole region (285 000 inhabitants) and has followed almost all the CF patients since 1973. Molecular characterisation has been routinely performed on all CF patients since 1990' (unpublished results) . A total of 132 CF patients followed at the Clinique de Fibrose Kystique in SLSJ have now been genotyped. Three mutations account for 87.6% of the CF chromosomes; these are the AF508 (57.6%), the 621+1G&-T (21.7%), and the A455E (8.3%) mutations.
Twenty patients (15.2%) had meconium ileus (MI). Although two or more sibs were affected with CF in some families, recurrence of MI in the same family was not observed. Fifteen different genotypes were identified in SLSJ (table 1) . The AF508/AF508 genotype accounted for 39.4% of all the CF patients, but 26.3% of the MI patients. Although accounting for only 25.8% of the CF patients, the AF508/621+1G-+T genotype was found in 47.4% of the patients with meconium ileus. Two of the six patients homozygous for the 621+1G-4T mutation, but none of the 23 CF patients heterozygous for the A455E mutation, had MI.
All 20 patients with MI had pancreatic insufficiency (PI) in infancy. However, there were differences in the risk of having MI among genotypes associated with PI. We previously showed that the 621+1G-4T mutation was associated with more severe gastrointestinal disease.5' CF patients heterozygous for the 621+1G-*T mutation and another "severe" mutation definitely appear to be at a higher risk of having meconium ileus. Although the A455E mutation is p=1.00
DIOS=distal intestinal obstruction syndrome. *Including two with cirrhosis.
considered to be a "mild" mutation, 13 of the 22 patients from SLSJ carrying a AF508/ A455E or a 621+1G-4T/A455E genotype had PI.5 However, none of them had MI. We reviewed published reports to calculate the rate of MI for specific genotypes (data available upon request). All the genotypes with which no case of MI was identified involved at least one "mild" CFTR allele conferring pancreatic sufficiency. Differences in the rate of MI were also observed among the genotypes made up of two "severe" alleles and even between the four series of patients homozygous for the AF508 mutation; however, in the latter situation, the difference was not significant (p=0.35). All the available data suggest that meconium ileus among genotypes associated with PI is partially genetically determined. It is also evident that other genetic/environmental factors play a role in determining the MI phenotype.
We No statistically significant differences between patients with or without MI were found in the weight and height parameters, nor in the sweat chloride concentration, the pulmonary function tests, or in the rate of colonisation with bacteria often found in CF patients.
More patients with MI experienced recurrrent abdominal pain and had DIOS than non-MI patients (p=0.035 and p=0.016, respectively). Five MI patients had diabetes mellitus but none without MI (p=0.016). In fact, of the eight patients with diabetes mellitus followed in Chicoutimi, five had MI (62.5%). Therefore, it appears that MI patients are at a higher risk of developing some specific clinical complications than non-MI patients. We have also observed' that mothers of infants with blastogenetic defects have a higher proportion of previous abortions that may mask the recurrence risk. However, we consider that in cases of holoprosencephaly (with different degrees of severity) and sirenomelia, in the absence of chromosomal abnormalities and maternal diabetes, the recurrence risk at birth should be very low.
We think that it is important to present this case in detail since, at present, it is the only one that has the two most severe forms of alteration of the cephalic and caudal part of the embryo (cyclopia and sirenomelia), and also because it was identified among a series of consecutive births, which allows the estimation of the birth prevalence of this entity. 
